Supplemental Figure 2 from Antitumor Activity of Novel Transcriptional Inhibitors Ecubectedin and PM54 in Soft Tissue Sarcoma Patient-Derived Xenografts

Supplemental Figure 2: Evolution of absolute tumor volume of individual tumors from day 1 to day 16 (A-F) or from day 1 to day 17 and to day 41 (G). Statistical significance indicate either tumor growth or shrinkage, whereas non-significance indicates tumor volume stabilization. * p<0.05, CRS: CIC-rearranged sarcoma; DDLPS: dedifferentiated liposarcoma; LMS: leiomyosarcoma; STS: soft tissue sarcoma; TV: tumor volume; ns: not significant; SynSa: synovial sarcoma.